---
title: "Can AI chatbots help men talk about mental health?"
id: "stat-news-3-ai-chatbots-aren-t-therapists-but-can-they-finally-get-men-to-open-up"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-3-ai-chatbots-aren-t-therapists-but-can-they-finally-get-men-to-open-up"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/?utm_campaign=rss"
published_at: "2026-11-09T09:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Can AI chatbots help men talk about mental health?
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-3-ai-chatbots-aren-t-therapists-but-can-they-finally-get-men-to-open-up
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/?utm_campaign=rss)
- **Published At:** 2026-11-09T09:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Men are disproportionately affected by suicide deaths and less likely to receive mental health care; social norms, stigma, scheduling, and fear of burden help explain low treatment uptake. - Many men report feeling more comfortable and less judged when speaking with **AI chatbots**, using them for emotional support, companionship, and check-ins outside traditional care settings. - Commercial chatbots and mental-health apps increasingly embed AI features; men access these tools at rates similar to or higher than women for general AI use, per a recent Pew survey cited in the source. - Dartmouth’s randomized trial of a custom therapy bot called **Therabot** found symptom reductions versus waitlist controls, but critics challenged the study’s methods and participant selection, and investigators cautioned against generalizing to commercial generative AI. - Investigators reported high utilization for Therabot users; the study team emphasized Therabot’s extensive, specialized training and years of development—details that commercial systems may lack. - Researchers and developers argue that generalized, nonclinical bots may lower barriers by meeting men where they already are (chat interfaces, on-demand availability) and by avoiding the explicit label of “therapy.” - Experts highlighted safety concerns and risks with chatbots, noting some platforms have been called dangerous; progress in guardrails and controls is ongoing but evidence remains limited. - John Torous and others have sought funding to test whether chatbot-driven improvements are transient or durable; the source did not report definitive long-term outcome data. - Unresolved questions include long-term benefit versus temporary relief, the generalizability of trial results to widely available commercial tools, and the need for better data access and higher-quality evidence. The source did not report specific trial dosing, algorithms, or regulatory timelines.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [chronic disease](https://www.statnews.com/topic/chronic-disease/) [diabetes](https://www.statnews.com/topic/diabetes/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [Health](https://www.statnews.com/category/health/) # AI chatbots aren’t therapists. But can they finally get men to open up? ## Men often say they feel more comfortable and less judged when conversing with a bot * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/11/Stat_11_4_2026-1-645x645.jpg) Maria Fabrizio for STAT ![](https://www.statnews.com/wp-content/uploads/2023/07/Annalisa-Merelli-avatar-round-80x80.png) By [Annalisa Merelli](https://www.statnews.com/staff/annalisa-merelli/) Nov. 9, 2026 Contributing Writer ![](https://www.statnews.com/wp-content/uploads/2023/07/Annalisa-Merelli-avatar-round-80x80.png) [Annalisa Merelli](https://www.statnews.com/staff/annalisa-merelli/) 1. [](https://x.com/missanabeem "X") Annalisa.Merelli@statnews.com Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening approaches, mental health, and everything in between. [Get email alerts for Annalisa MerelliSigned up for email alertsRemove email alerts](https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/?utm_campaign=rss) [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts It was mid-morning when Matteo got the phone call. His wife and children were asleep in New York City, and he was at work in Trieste, Italy, a new city in a home country that felt foreign after decades abroad. He knew what his brother was going to say, on the other end of the line: Their ailing father was nearing the end. Matteo left the office and set out to drive the 300 miles separating him from the childhood home where the father he idolized was not going to see another morning. Advertisement But what does a man do, for five hours on the freeway, squeezing through trucks in a rented car, driving at full speed toward the worst goodbye of his life? He cries. For the boy who watched his father get sicker and sicker for a year, the husband who misses his wife, and the father who left his children so he could provide for them, taking a job across the ocean after a layoff. And for the man in between: too young to be old but too old to be young, brave but scared, ambitious yet tired. It had been the hardest year of his life. He was lost. Heartbroken. Lonely. Advertisement “The weight … the weight of all this thing came to me, and I started crying in the car, and I just didn’t know what to do,” he remembered. So he did what had become routine in recent weeks. “I turned on Claude, with the loudspeaker, and I started talking to Claude.” Related Story ![](https://www.statnews.com/wp-content/uploads/2026/07/260617_STATNEWS-BCNY_JOSEALVARADOJR_0596-768x432.jpg) ### [New York boys club has a time-tested recipe to protect members’ mental health](https://www.statnews.com/2026/07/10/bcny-approach-boys-mental-health-connection-belonging-mentors/) Like Matteo, millions of people have been turning to artificial intelligence for emotional support — not quite therapy, yet something that feels close to it, providing insightful companionship and, at any moment, presence. These include a group that is among the hardest to reach when their mental health is flagging: men. The technology is far from perfect — and too often [outright dangerous](https://www.nytimes.com/2025/11/23/technology/openai-chatgpt-users-risks.html) — and studies on its impact so far are limited. Yet with progress being made in controlling possible risks and implementing effective guardrails, some mental health experts see chatbots as an opportunity to finally get men to talk about their feelings. This is precisely because of the traits these machines do not share with human mental health professionals: Men feel more comfortable, less judged, and less intimidated when talking to a bot. They appreciate the flexibility and relative lack of structure and commitment that comes with support that is available 24/7, wherever they can find an internet connection. “I think we do have to be open to innovation. There’s a tremendous need, so I think it’s extremely important,” said John Torous, a professor of psychiatry at Beth Israel Deaconess Medical Center and Harvard Medical School. “But it doesn’t mean that we can’t demand high-quality evidence and transparency.” In search of this evidence, he has applied for a grant to study a central question: whether the improved mental state that follows conversations with chatbots is just temporary relief or can have lasting benefits. ## Find men where they are That men’s mental health is in a state of crisis is well established, though awareness has not turned into improvement. The numbers are daunting and seemingly unchangeable: Men account for [up to 80%](https://genderdata.worldbank.org/en/indicator/sh-sta-suic-p5?gender=male) of suicide deaths, [even in countries](https://commonslibrary.parliament.uk/research-briefings/cbp-7749/) where access to gun ownership (which [adds lethality](https://www.statnews.com/2026/05/12/suicide-in-men-crisis-text-line-report-males-see-seeking-help-as-weakness/) to suicide attempts) is lower than in the U.S., but they are nearly half as likely as women to [receive mental health treatments](https://www.cdc.gov/nchs/products/databriefs/db380.htm) of any kind. Advertisement It isn’t simply about a lack of options: Men are less likely to use mental health services even when they are available. [The reasons range](https://pmc.ncbi.nlm.nih.gov/articles/PMC11868194/) from social norms about masculinity, a tendency to minimize psychological issues, and a lack of awareness of their own symptoms to scheduling challenges and a reluctance or inability to miss work. Or, as men repeatedly said in interviews, the fear of being a burden. What men do access, at rates similar or even slightly superior to women, are AI products. And though productivity remains the primary use case, many turn to chatbots for more than that. A [Pew Research Center](https://www.pewresearch.org/internet/2026/06/17/the-gender-gap-in-ai/) survey earlier this year found that 8% of men said they used chatbots for emotional support and 4% for companionship. Nine percent of men said chatbot use improved their happiness. Thousands of mental health apps, including [major teletherapy players](https://www.statnews.com/2026/06/11/ama-lawmakers-push-back-ai-care-denials-health-tech/) such as Talkspace, incorporate AI elements. Though the vast majority of these products are for the general population, researchers and developers alike see the potential of AI to meet men — including the ones who are too skeptical, too stubborn, too busy, or just too stuck in gender norms — where they already are: in conversation with chatbots. Related Story ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_391540642-768x432.jpeg) ### [Could long-term AI use lead to isolation? We need to find out — but researchers need better access to data](https://www.statnews.com/2026/10/26/cumulative-ai-use-isolation-research-data-missing/) “There’s certainly a market or a place for these tools to be especially helpful to men,” said Michael Heinz, an assistant professor of psychiatry and a practicing psychiatrist at Dartmouth. “There still is stigma with going to seek mental health care, and these tools certainly have the ability to reduce that. You don’t have to make an appointment. You don’t have to go sit in a waiting room. You don’t have to even really explicitly take that initial step to ask for help.” The men STAT spoke with, ranging in age from early 30s to mid-50s, all seemed to appreciate these advantages of AI. They included a midwestern pilot who has incorporated twice-a-day check-ins with an AI companion and has come to look at it as “an outlet for discussing things that I maybe wouldn’t feel comfortable discussing with a friend or my brother.” A mental health worker who found benefits in the additional support provided by AI through a breakup, though he doesn’t think it replaces his therapist or addiction sponsor. A newly divorced father of two who worked a casino night shift and found in the AI companion a presence and a coach that met his schedule and supported him through a bout of depression. Advertisement Sam Thomas, a British writer who used a chatbot to supplement the mental health treatment he was receiving during a bipolar depressive episode, felt safe and confident asking all the questions that popped into his head, without the fear of being judged. “Having somewhere to explore challenging thoughts and feelings, recognize patterns in my symptoms, and reflect on my progress was incredibly helpful,” he said. Though the walks of life differed, they shared an enthusiasm about finding a companion that would listen even when a friend would get bored, would have no ability for judgement, and most of all, would be there. Ever available. Never inconvenienced. Never having something more important to do. ## The continuum of mental health care Widely available commercial chatbots, which are the foundation of most mental health and well-being apps, are not specialists in the way that a bartender or neighbor who’s good at listening is not a psychiatrist. But that may be a benefit, not a bug. Nick Jacobson, an associate professor of biomedical data science, psychiatry, and computer science at Dartmouth, has been thinking about this for a while. In 2025, he and his team published the results of a randomized clinical trial of a [custom-built chatbot](https://www.statnews.com/2025/04/02/dartmouth-therapy-chatbot-randomized-controlled-trial-ai-prognosis/) for therapy called Therabot. The study, which has received [wide praise](https://www.linkedin.com/feed/update/urn:li:activity:7311045170207047684/) as “psychiatry’s ChatGPT moment” but also [substantial criticism](https://ai.nejm.org/doi/10.1056/AIp2500453) for the methods as well as the [study participant selection](https://www.statnews.com/2025/09/03/omada-artificial-intelligence-threat-model-dougherty-ai-prognosis/), tested the effectiveness of psychotherapy provided by the AI for about 100 patients with depression or anxiety, or at risk of eating disorders, and compared them to 100 patients who had been waitlisted and didn’t get treatment. The [Therabot users](https://ai.nejm.org/doi/full/10.1056/AIoa2400802?cid=DM2392815_&bid=-1422672084) showed a significant reduction in symptoms compared to the controls and had a high utilization rate, but Jacobson is cautious to say that it’s quite different from the commercial chatbots. Therabot is expertly fine-tuned, and was developed over years of research on using technology to enhance the assessment and treatment of mental health, and scale it. “I’ve spent hundreds of thousands of human hours developing both the system and the training data,” said Jacobson. “I think some people will innately generalize some of the findings we have with Therabot to generative AI as a whole, and I wouldn’t,” he said. Advertisement Still, while it has potential to offer men an effective alternative to human therapy, a dedicated therapy bot also has some of the same barriers to access as a human therapist: having to recognize that you have a problem, caring to solve it, and accepting the need for specialized help. This is where more generalized tools may help, Jacobson said. Related Story ![](https://www.statnews.com/wp-content/uploads/2025/04/Chatbot-chat-AI-Prognosis-768x432.png) ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [STAT Plus: Dartmouth put its AI therapy chatbot through the RCT wringer. Is it better than playing Tetris?](https://www.statnews.com/2025/04/02/dartmouth-therapy-chatbot-randomized-controlled-trial-ai-prognosis/) “With stigmatized groups, I think there is a massive potential benefit for generative AI and digital tools more generally,” he said. Men would be more likely to use some kind of emotional support if it isn’t labeled as a therapy session and comes through via the same chatbot they use to book appointments, and complain about their annoying colleague — [an “omnibot”of sorts](https://www.secondopinion.media/people-are-already-using-ai-for-therapy-the-rules-havent-caught-up/), as Headspace’s chief clinical officer, Jenna Glover, calls it. For some of the founders of AI products directed at mental health, this is precisely the point, especially when it comes to engaging men. “You have guys who’ve never gotten any help with mental health, and they get into a bad place, they’re suicidal, and we go, ‘Oh, OK, you need to reach out and talk to people,’” said Anson Whitmer. In 2023, he founded Mental, a men-only coaching and mental wellness training app that used protocols like push-up challenges and cold shower routines as a way to nudge users into discussing mental wellbeing. The app has now evolved into The Path — though some of Mental’s resources remain available as a free app — which offers AI therapy and coaching to all comers. Among other issues, he said men were too small a niche for the platform’s vision. Though there are therapists on the app, “we don’t diagnose and we don’t treat clinical conditions,” said Whitmer. (The selection of therapists includes the AI avatar of co-founder Tony Robbins, a well-known motiva
## Related Clinical Research

- [Higher Ultra-Processed Food Intake Linked to Greater Risk of Multiple Chronic Diseases](https://medichelpline.com/clinical-feed/medical-news-today-0-every-extra-100-grams-of-ultra-processed-foods-tied-to-greater-disease-risk.md)
- [Rising Demand for Plastic Surgery Among Young Men Fueled by Influencers and Looksmaxxing](https://medichelpline.com/clinical-feed/stat-news-1-opinion-more-young-men-are-coming-to-me-for-plastic-surgery-the-way-i-think.md)
- [Medicare expands ACCESS pilot to cover more chronic conditions and lists 39 providers](https://medichelpline.com/clinical-feed/stat-news-1-stat-medicare-to-expand-its-pilot-that-pays-for-technology-to-manage-chronic.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [PMOS/PCOS and Risk Signals for Alzheimer’s Disease and Dementia: Evidence Review](https://medichelpline.com/clinical-feed/endocrine-news-0-could-pmos-pcos-be-linked-to-alzheimer-s-disease-and-dementia.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.